Article

A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease

2022-04-01

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Interstitial lung disease (ILD) is a known complication of rheumatoid arthritis (RA) with a lifetime risk in any individual of 7.7%. The TRAIL1 trial was a randomized, double-blinded, placebo-controlled, phase 2 study of safety, tolerability, and efficacy of pirfenidone for the treatment of patients with RA-ILD. <h4>Methods</h4> The TRAIL1 was a phase 2 trial intended to enrol...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f3e15b1f-f882-5fd1-a67b-e5df820e8ae7
DOI: 10.1101/2022.04.01.22273270

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung DiseaseDOI 10.1101/2022.04.01.22273270Read

Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis.Semantic proximity Read

Combined therapy with pirfenidone and nintedanib counteracts fibrotic silicosis in miceSemantic proximity Read

[How i treat a patient with idiopathic pulmonary fibrosis].Semantic proximity Read

Pharmacological Immunomodulation by Collagen-Polyvinylpyrrolidone or Pirfenidone Plays a Role in the Recovery of Patients with Severe COVID-19, Through a Similar Mechanism of Action Involving the JAK-STAT Signaling Pathway. Pilot StudySemantic proximity Read

Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutationSemantic proximity Read

Progressive fibrotic interstitial lung disease.Semantic proximity Read

Prolonged-release pirfenidone in patients with pulmonary fibrosis as a phenotype of post-acute sequelae of COVID-19 pneumonia. Safety and efficacy.Semantic proximity Read

Methotrexate for the treatment of osteoarthritis: a systematic review and meta-analysis of randomized controlled trialsSemantic proximity Read

Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study.Semantic proximity Read

Patient-Reported Outcomes of Upadacitinib Versus Abatacept in Patients with Rheumatoid Arthritis and an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: 12-Week Results of a Phase 3 TrialSemantic proximity Read

Differences and Similarities in Clinical and Functional Responses Among Patients Receiving Tofacitinib Monotherapy, Tofacitinib Plus Methotrexate, and Adalimumab Plus Methotrexate: A Post-hoc Analysis of Data From Oral StrategySemantic proximity Read

Safety Analysis of Biologic Therapies for Chronic Obstructive Pulmonary Disease: A Real-World Study Based on the FAERS DatabaseSemantic proximity Read